Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-021261

Director acquired 2,377 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Molineaux Christopher P. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2018-03-20 Exercise or conversion : show line 1 in the form +1,993 $0.41 $817 9,598 D
2018-03-20 Exercise or conversion : show line 2 in the form +120 $0.72 $86 9,718 D
2018-03-20 Exercise or conversion : show line 3 in the form +264 $1.52 $401 9,982 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-03-20 Exercise or conversion : show line 4 in the form Stock option (right to buy) −1,993 0 D
2018-03-20 Exercise or conversion : show line 5 in the form Stock option (right to buy) −120 51 D
2018-03-20 Exercise or conversion : show line 6 in the form Stock option (right to buy) −264 198 D
Loading xslF345X03/doc4.xml…